A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://link.springer.com/article/10.1007/s10439-019-02269-2 below:

Development of a Colorectal Cancer 3D Micro-tumor Construct Platform From Cell Lines and Patient Tumor Biospecimens for Standard-of-Care and Experimental Drug Screening

References

  1. Ahmed, D., P. W. Eide, I. A. Eilertsen, S. A. Danielsen, M. Eknaes, M. Hektoen, G. E. Lind, and R. A. Lothe. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis 2:e71, 2013.

    Article  CAS  Google Scholar 

  2. Ahronian, L. G., E. M. Sennott, E. M. Van Allen, N. Wagle, E. L. Kwak, J. E. Faris, J. T. Godfrey, K. Nishimura, K. D. Lynch, C. H. Mermel, E. L. Lockerman, A. Kalsy, J. M. Gurski, Jr, S. Bahl, K. Anderka, L. M. Green, N. J. Lennon, T. G. Huynh, M. Mino-Kenudson, G. Getz, D. Dias-Santagata, A. J. Iafrate, J. A. Engelman, L. A. Garraway, and R. B. Corcoran. Clinical acquired resistance to RAF inhibitor combinations in BRAF-mutant colorectal cancer through MAPK pathway alterations. Cancer Discov. 5:358–367, 2015.

    Article  CAS  Google Scholar 

  3. Armaghany, T., J. D. Wilson, Q. Chu, and G. Mills. Genetic alterations in colorectal cancer. Gastrointest. Cancer Res. 5:19–27, 2012.

    PubMed  PubMed Central  Google Scholar 

  4. Berg, K. C. G., P. W. Eide, I. A. Eilertsen, B. Johannessen, J. Bruun, S. A. Danielsen, M. Bjornslett, L. A. Meza-Zepeda, M. Eknaes, G. E. Lind, O. Myklebost, R. I. Skotheim, A. Sveen, and R. A. Lothe. Multi-omics of 34 colorectal cancer cell lines—a resource for biomedical studies. Mol. Cancer 16:116, 2017.

    Article  Google Scholar 

  5. Breslin, S., and L. O’Driscoll. The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance. Oncotarget 7:45745–45756, 2016.

    Article  Google Scholar 

  6. Chin, L., J. N. Andersen, and P. A. Futreal. Cancer genomics: from discovery science to personalized medicine. Nat. Med. 17:297–303, 2011.

    Article  CAS  Google Scholar 

  7. de Gramont, A. F. A., M. Seymour, M. Homerin, A. Hmissi, J. Cassidy, C. Boni, H. Cortes-Funes, A. Cervantes, G. Freyer, D. Papamichael, N. Le Bail, C. Louvet, D. Hendler, F. de Braud, C. Wilson, F. Morvan, and A. Bonetti. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J. Clin. Oncol. 18:2938–2947, 2000.

    Article  Google Scholar 

  8. De Rosa, M., U. Pace, D. Rega, V. Costabile, F. Duraturo, P. Izzo, and P. Delrio. Genetics, diagnosis and management of colorectal cancer (Review). Oncol. Rep. 34:1087–1096, 2015.

    Article  Google Scholar 

  9. Edmondson, R., J. J. Broglie, A. F. Adcock, and L. Yang. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev. Technol. 12:207–218, 2014.

    Article  CAS  Google Scholar 

  10. Fleming, M., S. Ravula, S. F. Tatishchev, and H. L. Wang. Colorectal carcinoma: pathologic aspects. J. Gastrointest. Oncol. 3:153–173, 2012.

    PubMed  PubMed Central  Google Scholar 

  11. Gilbert, C. A., and A. H. Ross. Cancer stem cells: cell culture, markers, and targets for new therapies. J. Cell. Biochem. 108:1031–1038, 2009.

    Article  CAS  Google Scholar 

  12. Gmeiner, W. H., W. Debinski, C. Milligan, D. Caudell, and T. S. Pardee. The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence. Future Oncol. 12:2009–2020, 2016.

    Article  CAS  Google Scholar 

  13. Greystoke, A., M. Ayub, D. G. Rothwell, D. Morris, D. Burt, C. L. Hodgkinson, C. J. Morrow, N. Smith, K. Aung, J. Valle, L. Carter, F. Blackhall, C. Dive, and G. Brady. Development of a circulating miRNA assay to monitor tumor burden: from mouse to man. Mol. Oncol. 10:282–291, 2016.

    Article  CAS  Google Scholar 

  14. Hamburg, M. A., and F. S. Collins. The path to personalized medicine. N. Engl. J. Med. 363:301–304, 2010.

    Article  CAS  Google Scholar 

  15. Hu, T., Z. Li, C. Y. Gao, and C. H. Cho. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J. Gastroenterol. 22:6876–6889, 2016.

    Article  CAS  Google Scholar 

  16. Institute N. S. Cancer Stat Facts: Colon and Rectum Cancer. Bethesda: NIH, 2017.

    Google Scholar 

  17. Kapalczynska, M., T. Kolenda, W. Przybyla, M. Zajaczkowska, A. Teresiak, V. Filas, M. Ibbs, R. Blizniak, L. Luczewski, and K. Lamperska. 2D and 3D cell cultures—a comparison of different types of cancer cell cultures. Arch. Med. Sci. 14:910–919, 2018.

    PubMed  Google Scholar 

  18. Karlsson, H., M. Fryknas, R. Larsson, and P. Nygren. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. Exp. Cell Res. 318:1577–1585, 2012.

    Article  CAS  Google Scholar 

  19. Katt, M. E., A. L. Placone, A. D. Wong, Z. S. Xu, and P. C. Searson. In Vitro tumor models: advantages, disadvantages, variables, and selecting the right platform. Front. Bioeng. Biotechnol. 4:12, 2016.

    Article  Google Scholar 

  20. Langhans, S. A. Three-dimensional in vitro cell culture models in drug discovery and drug repositioning. Front. Pharmacol. 9:6, 2018.

    Article  Google Scholar 

  21. Loessner, D., K. S. Stok, M. P. Lutolf, D. W. Hutmacher, J. A. Clements, and S. C. Rizzi. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 31:8494–8506, 2010.

    Article  CAS  Google Scholar 

  22. Luca, A. C., S. Mersch, R. Deenen, S. Schmidt, I. Messner, K. L. Schafer, S. E. Baldus, W. Huckenbeck, R. P. Piekorz, W. T. Knoefel, A. Krieg, and N. H. Stoecklein. Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS ONE 8:e59689, 2013.

    Article  CAS  Google Scholar 

  23. Mazzocchi, A. R., S. A. P. Rajan, K. I. Votanopoulos, A. R. Hall, and A. Skardal. In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening. Sci. Rep. 8:2886, 2018.

    Article  Google Scholar 

  24. Mazzocchi, A. R., S. Soker, and A. Skardal. Biofabrication technologies for developing in vitro tumor models. In: Tumor Organoids, edited by S. Soker, and A. Skardal. Berlin, Germany: Springer Nature, 2017, pp. 51–70.

    Google Scholar 

  25. Miserocchi, G., L. Mercatali, C. Liverani, A. De Vita, C. Spadazzi, F. Pieri, A. Bongiovanni, F. Recine, D. Amadori, and T. Ibrahim. Management and potentialities of primary cancer cultures in preclinical and translational studies. J. Transl. Med. 15:229, 2017.

    Article  Google Scholar 

  26. Parasuraman, S. Toxicological screening. J. Pharmacol. Pharmacother. 2:74–79, 2011.

    Article  CAS  Google Scholar 

  27. Riedl, A., M. Schlederer, K. Pudelko, M. Stadler, S. Walter, D. Unterleuthner, C. Unger, N. Kramer, M. Hengstschlager, L. Kenner, D. Pfeiffer, G. Krupitza, and H. Dolznig. Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses. J. Cell Sci. 130:203–218, 2017.

    Article  CAS  Google Scholar 

  28. Sameer, A. S. Colorectal cancer: molecular mutations and polymorphisms. Front. Oncol. 3:114, 2013.

    Article  Google Scholar 

  29. Scholzen, T., and J. Gerdes. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 182:311–322, 2000.

    Article  CAS  Google Scholar 

  30. Siegel, R. L., K. D. Miller, S. A. Fedewa, D. J. Ahnen, R. G. S. Meester, A. Barzi, and A. Jemal. Colorectal cancer statistics, 2017. CA Cancer J. Clin. 67:177–193, 2017.

    Article  Google Scholar 

  31. Skardal, A. Biopolymers for in vitro tissue model biofabrication. In: Biopolymers for Medical Applications, edited by J. M. Ruso, and P. V. Messina. Boca Raton, FL: CRC Press, 2016.

    Google Scholar 

  32. Skardal, A., M. Devarasetty, S. Forsythe, A. Atala, and S. Soker. A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening. Biotechnol. Bioeng. 113:2020–2032, 2016.

    Article  CAS  Google Scholar 

  33. Skardal, A., M. Devarasetty, C. Rodman, A. Atala, and S. Soker. Liver-tumor hybrid organoids for modeling tumor growth and drug response in vitro. Ann. Biomed. Eng. 43:2361–2373, 2015.

    Article  Google Scholar 

  34. Skardal, A., L. Smith, S. Bharadwaj, A. Atala, S. Soker, and Y. Zhang. Tissue specific synthetic ECM hydrogels for 3-D in vitro maintenance of hepatocyte function. Biomaterials 33:4565–4575, 2012.

    Article  CAS  Google Scholar 

  35. Votanopoulos, K. I., A. Mazzocchi, H. Sivakumar, S. Forsythe, J. Aleman, E. A. Levine, and A. Skardal. Appendiceal cancer patient-specific tumor organoid model for predicting chemotherapy efficacy prior to initiation of treatment: a feasibility study. Ann. Surg. Oncol. 26:139–147, 2019.

    Article  Google Scholar 

Download references

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.4